{
  "frames":[
    {
      "frame-id":"evem-PMC2120229-UAZ-r1-1-5-1",
      "text":"hypophosphorylated form of p110RB",
      "arguments":[
        {
          "text":"p110RB",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2120229-UAZ-r1-1-5-12"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2120229-UAZ-r1-1",
        "offset":896,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2120229-UAZ-r1-1",
        "offset":863,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2120229-UAZ-r1-1-5",
      "found-by":"Phosphorylation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Furthermore , both in vivo and in vitro experiments demonstrate that p84 binds preferentially to the functionally active , hypophosphorylated form of p110RB ."
    }
  ],
  "object-type":"frame-collection",
  "object-meta":{
    "processing-end":"2015-06-14T20:59:52Z",
    "doc-id":"PMC2120229",
    "component-type":"machine",
    "component":"REACH",
    "processing-start":"2015-06-14T20:59:49Z",
    "object-type":"meta-info",
    "organization":"UAZ"
  }
}
